CEPORACIN POWDER FOR SOLUTION

Valsts: Kanāda

Valoda: angļu

Klimata pārmaiņas: Health Canada

Aktīvā sastāvdaļa:

CEPHALOTHIN (CEPHALOTHIN SODIUM)

Pieejams no:

MYLAN PHARMACEUTICALS ULC

ATĶ kods:

J01DB03

SNN (starptautisko nepatentēto nosaukumu):

CEFALOTIN

Deva:

1G

Zāļu forma:

POWDER FOR SOLUTION

Kompozīcija:

CEPHALOTHIN (CEPHALOTHIN SODIUM) 1G

Ievadīšanas:

INTRAMUSCULAR

Vienības iepakojumā:

1G

Receptes veids:

Prescription

Ārstniecības joma:

FIRST GENERATION CEPHALOSPORINS

Produktu pārskats:

Active ingredient group (AIG) number: 0105868001; AHFS:

Autorizācija statuss:

CANCELLED POST MARKET

Autorizācija datums:

2015-11-03

Produkta apraksts

Prescribing Information
CEPORACIN
®
Cephalothin Sodium BP for Injection
1 g/vial
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke, ON
M8Z 2S6
Date of Preparation:
March 31, 2014
Submission Control No: 172067
Pr
Ceporacin
®
I.V./I.M
Cephalothin Sodium BP for Injection
THERAPEUTIC CATEGORY: ANTIBIOTIC
ACTION:
Ceporacin
®
(cephalothin sodium) is a bacterial antibiotic. It kills susceptible
bacterial cells by
inhibiting cell wall synthesis.
INDICATIONS:
May be indicated for the treatment of serious infections caused by
susceptible strains of the
designated microorganisms in the diseases listed below. Culture and
susceptibility studies should
be performed. Clinical judgement and anticipated bacteriological
findings may permit the start of
therapy before results of susceptibility studies are obtained.
Respiratory tract infections caused
by _S. pneumonia, staphylococcus spp._ (beta-lactamase and
nonbeta-lactamase (penicillinase)
producing). Group A beta-hemolytic _streptococcus spp._, _Klebsiella
spp._, and _H.influenzae._
Skin and soft tissue infections, including peritonitis caused by
_staphylococcus spp._ (beta-
lactamase and nonbeta-lactamase producing). Group A beta-hemolytic
_streptococcus spp._, _E. _
_coli, P.mirabilis_, and _Klebsiella spp._
Genitourinary tract infections caused by _E. coli, P.mirabilis_, and
_Klebsiella spp._
Septicemia, including endocarditis, caused by _S.pneumoniae,_
_staphylococcus spp._ (beta-
lactamase and nonbeta-lactamase producing). Group A beta-hemolytic
_streptococcus spp._,
_S.viridans,_ _E. coli, P.mirabilis_, and _Klebsiella spp._
Meningitis cause by _S.pneumoniae, _Group A beta-hemolytic
_streptococcus spp._ and
_staphylococcus spp._ (beta-lactamase and nonbeta-lactamase
producing).
Bone and joint infections caused by _staphylococcus spp._
(beta-lactamase and nonbeta-lactamase
producing).
Evidence indicates that perioperative administration of cephalothin
sodium may help to reduce
the incidence of postoperative infections in patients undergoing
surgical procedures involvin